Importance: With the approval of transcatheter aortic valve replacement (TAVR) for patients with severe symptomatic aortic stenosis at intermediate surgical risk, TAVR volume is projected to increase exponentially in the United States. The 30-day readmission rate for TAVR was recently reported at 17.9%. The association between institutional TAVR volume and the 30-day readmission metric has not been examined. Objective: To assess the association between hospital TAVR volume and 30-day readmission. Design, Setting, and Participants: In this observational study, we used the 2014 Nationwide Readmissions Database to identify hospitals with established TAVR programs (performing at least 5 TAVRs in the first quarter of 2014). Based on annual TAVR volume, hospitals were classified as low (<50), medium (≥50 to <100), and high (≥100) volume. Rates, causes, and costs of 30-day readmissions were compared between low-, medium-, and high-volume hospitals. Data were analyzed from November to December 2016. Exposure: Transcatheter aortic valve replacement. Main Outcomes and Measures: Thirty-day readmissions. Results: Of 129 hospitals included in this study, 20 (15.5%) were categorized as low volume, 47 (36.4%) as medium volume, and 62 (48.1%) as high volume. Of 16 252 index TAVR procedures, 663 (4.1%), 3067 (18.9%), and 12 522 (77.0%) were performed at low-, medium-, and high-volume hospitals, respectively. Thirty-day readmission rates were significantly lower in high-volume compared with medium-volume (adjusted odds ratio, 0.76; 95% CI, 0.68-0.85; P < .001) and low-volume (adjusted odds ratio, 0.75; 95% CI, 0.60-0.92; P = .007) hospitals. Noncardiac readmissions were more common in low-volume hospitals (65.6% vs 60.6% in high-volume hospitals), whereas cardiac readmissions were more common in high-volume hospitals (39.4% vs 34.4% in low-volume hospitals). There were no significant differences in length of stay and costs per readmission among the 3 groups (mean [SD], 5.5 [5.0] days vs 5.9 [7.5] days vs 6.0 [5.8] days; P = .74, and $13 886 [18 333] vs $14 135 [17 939] vs $13 432 [15 725]; P = .63, respectively). Conclusions and Relevance: We report for the first time, to our knowledge, an inverse association between hospital TAVR volume and 30-day readmissions. Lower readmission at higher-volume hospitals was associated with significantly lower cost to the health care system.
Importance: With the approval of transcatheter aortic valve replacement (TAVR) for patients with severe symptomatic aortic stenosis at intermediate surgical risk, TAVR volume is projected to increase exponentially in the United States. The 30-day readmission rate for TAVR was recently reported at 17.9%. The association between institutional TAVR volume and the 30-day readmission metric has not been examined. Objective: To assess the association between hospital TAVR volume and 30-day readmission. Design, Setting, and Participants: In this observational study, we used the 2014 Nationwide Readmissions Database to identify hospitals with established TAVR programs (performing at least 5 TAVRs in the first quarter of 2014). Based on annual TAVR volume, hospitals were classified as low (<50), medium (≥50 to <100), and high (≥100) volume. Rates, causes, and costs of 30-day readmissions were compared between low-, medium-, and high-volume hospitals. Data were analyzed from November to December 2016. Exposure: Transcatheter aortic valve replacement. Main Outcomes and Measures: Thirty-day readmissions. Results: Of 129 hospitals included in this study, 20 (15.5%) were categorized as low volume, 47 (36.4%) as medium volume, and 62 (48.1%) as high volume. Of 16 252 index TAVR procedures, 663 (4.1%), 3067 (18.9%), and 12 522 (77.0%) were performed at low-, medium-, and high-volume hospitals, respectively. Thirty-day readmission rates were significantly lower in high-volume compared with medium-volume (adjusted odds ratio, 0.76; 95% CI, 0.68-0.85; P < .001) and low-volume (adjusted odds ratio, 0.75; 95% CI, 0.60-0.92; P = .007) hospitals. Noncardiac readmissions were more common in low-volume hospitals (65.6% vs 60.6% in high-volume hospitals), whereas cardiac readmissions were more common in high-volume hospitals (39.4% vs 34.4% in low-volume hospitals). There were no significant differences in length of stay and costs per readmission among the 3 groups (mean [SD], 5.5 [5.0] days vs 5.9 [7.5] days vs 6.0 [5.8] days; P = .74, and $13 886 [18 333] vs $14 135 [17 939] vs $13 432 [15 725]; P = .63, respectively). Conclusions and Relevance: We report for the first time, to our knowledge, an inverse association between hospital TAVR volume and 30-day readmissions. Lower readmission at higher-volume hospitals was associated with significantly lower cost to the health care system.
Authors: Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock Journal: N Engl J Med Date: 2011-06-05 Impact factor: 91.245
Authors: Dhaval Kolte; Sahil Khera; M Rizwan Sardar; Neil Gheewala; Tanush Gupta; Saurav Chatterjee; Andrew Goldsweig; Wilbert S Aronow; Gregg C Fonarow; Deepak L Bhatt; Adam B Greenbaum; Paul C Gordon; Barry Sharaf; J Dawn Abbott Journal: Circ Cardiovasc Interv Date: 2017-01 Impact factor: 6.546
Authors: George C M Siontis; Peter Jüni; Thomas Pilgrim; Stefan Stortecky; Lutz Büllesfeld; Bernhard Meier; Peter Wenaweser; Stephan Windecker Journal: J Am Coll Cardiol Date: 2014-07-15 Impact factor: 24.094
Authors: Gabriela Tirado-Conte; Afonso B Freitas-Ferraz; Luis Nombela-Franco; Pilar Jimenez-Quevedo; Corina Biagioni; Ana Cuadrado; Ivan Nuñez-Gil; Pablo Salinas; Nieves Gonzalo; Carlos Ferrera; David Vivas; Javier Higueras; Ana Viana-Tejedor; Maria Jose Perez-Vizcayno; Isidre Vilacosta; Javier Escaned; Antonio Fernandez-Ortiz; Carlos Macaya Journal: Am J Cardiol Date: 2016-05-14 Impact factor: 2.778
Authors: Robert M A van der Boon; Bertrand Marcheix; Didier Tchetche; Alaide Chieffo; Nicolas M Van Mieghem; Nicolas Dumonteil; Olivier Vahdat; Francesco Maisano; Patrick W Serruys; A Pieter Kappetein; Jean Fajadet; Antonio Colombo; Didier Carrié; Ron T van Domburg; Peter P T de Jaegere Journal: Ann Thorac Surg Date: 2013-11-19 Impact factor: 4.330
Authors: Martin B Leon; Craig R Smith; Michael J Mack; Raj R Makkar; Lars G Svensson; Susheel K Kodali; Vinod H Thourani; E Murat Tuzcu; D Craig Miller; Howard C Herrmann; Darshan Doshi; David J Cohen; Augusto D Pichard; Samir Kapadia; Todd Dewey; Vasilis Babaliaros; Wilson Y Szeto; Mathew R Williams; Dean Kereiakes; Alan Zajarias; Kevin L Greason; Brian K Whisenant; Robert W Hodson; Jeffrey W Moses; Alfredo Trento; David L Brown; William F Fearon; Philippe Pibarot; Rebecca T Hahn; Wael A Jaber; William N Anderson; Maria C Alu; John G Webb Journal: N Engl J Med Date: 2016-04-02 Impact factor: 91.245
Authors: Rohan Khera; Ambarish Pandey; Thomas Koshy; Colby Ayers; Brahmajee K Nallamothu; Sandeep R Das; Mark H Drazner; Michael E Jessen; Ajay J Kirtane; Timothy J Gardner; James A de Lemos; Deepak L Bhatt; Dharam J Kumbhani Journal: JAMA Cardiol Date: 2017-12-01 Impact factor: 14.676
Authors: Quinn P Hosler; Anthony J Maltagliati; Sandra M Shi; Jonathan Afilalo; Jeffrey J Popma; Kamal R Khabbaz; Roger J Laham; Kimberly Guibone; Dae Hyun Kim Journal: J Am Geriatr Soc Date: 2019-06-18 Impact factor: 5.562
Authors: Mourad H Senussi; John Schindler; Ibrahim Sultan; Ahmad Masri; Forozan Navid; Dustin Kliner; Arman Kilic; Michael S Sharbaugh; Amr Barakat; Andrew D Althouse; Joon S Lee; Thomas G Gleason; Suresh R Mulukutla Journal: Cardiovasc Diagn Ther Date: 2021-08
Authors: Saraschandra Vallabhajosyula; Sri Harsha Patlolla; Harigopal Sandhyavenu; Saarwaani Vallabhajosyula; Gregory W Barsness; Shannon M Dunlay; Kevin L Greason; David R Holmes; Mackram F Eleid Journal: J Am Heart Assoc Date: 2018-07-09 Impact factor: 5.501
Authors: Gabby Elbaz-Greener; Feng Qiu; John G Webb; Kayley A Henning; Dennis T Ko; Andrew Czarnecki; Idan Roifman; Peter C Austin; Harindra C Wijeysundera Journal: J Am Heart Assoc Date: 2019-06-05 Impact factor: 5.501
Authors: Carolyn E Horne; Tamara S Goda; L Wiley Nifong; Alan P Kypson; Wesley T O'Neal; Linda C Kindell; Charulata Jindal; Jimmy T Efird Journal: Int J Environ Res Public Health Date: 2018-12-28 Impact factor: 3.390
Authors: Amgad Mentias; Marwan Saad; Milind Y Desai; Phillip A Horwitz; James D Rossen; Sidakpal Panaich; Ayman Elbadawi; Abdul Qazi; Paul Sorajja; Hani Jneid; Samir Kapadia; Barry London; Mary S Vaughan Sarrazin Journal: J Am Heart Assoc Date: 2019-10-31 Impact factor: 5.501